Revvity to Present at Upcoming Investor Conferences
August 21 2024 - 8:00AM
Business Wire
Revvity, Inc. (NYSE: RVTY), today announced it will present at
the following investor conferences in September 2024:
2024 Wells Fargo Healthcare Conference – Boston, MA Wednesday,
September 4, 2024 8:45 a.m. ET - Max Krakowiak, senior vice
president and chief financial officer
2024 Baird Global Healthcare Conference – New York City, NY
Tuesday, September 10, 2024 12:15 p.m. ET - Steve Willoughby,
senior vice president, investor relations, ESG, risk
Attendees will receive an update on the Company and its
strategic priorities.
Live audio webcasts will be available on the Events section of
the Company’s website. Replays of the presentations will be posted
on the Revvity Investor Relations website after the events and will
be available for at least 30 days.
About Revvity At Revvity, “impossible” is inspiration,
and “can’t be done” is a call to action. Revvity provides health
science solutions, technologies, expertise, and services that
deliver complete workflows from discovery to development, and
diagnosis to cure. Revvity is revolutionizing what’s possible in
healthcare, with specialized focus areas in translational
multi-omics technologies, biomarker identification, imaging,
prediction, screening, detection and diagnosis, informatics and
more.
With 2023 revenue of more than $2.7 billion and over 11,000
employees, Revvity serves customers across pharmaceutical and
biotech, diagnostic labs, academia and governments. It is part of
the S&P 500 index and has customers in more than 190
countries.
Stay updated by following our Newsroom, LinkedIn, X, YouTube,
Facebook and Instagram.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240821240750/en/
Media Relations: Chet Murray (781) 462-5126
chet.murray@revvity.com
Investor Relations: Steve Willoughby
steve.willoughby@revvity.com
Revvity (NYSE:RVTY)
Historical Stock Chart
From Jul 2024 to Aug 2024
Revvity (NYSE:RVTY)
Historical Stock Chart
From Aug 2023 to Aug 2024